Adlai Nortye (NASDAQ:ANL) Trading Up 7.7% – What’s Next?

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL)’s stock price was up 7.7% on Friday . The stock traded as high as $16.02 and last traded at $15.89. Approximately 194,152 shares were traded during trading, a decline of 50% from the average session volume of 386,535 shares. The stock had previously closed at $14.75.

Analysts Set New Price Targets

ANL has been the topic of a number of analyst reports. Cantor Fitzgerald started coverage on Adlai Nortye in a research report on Monday, June 22nd. They set an “overweight” rating on the stock. JonesTrading started coverage on Adlai Nortye in a research report on Thursday, May 14th. They set a “buy” rating and a $22.00 target price on the stock. Oppenheimer assumed coverage on shares of Adlai Nortye in a report on Thursday, May 28th. They issued an “outperform” rating and a $32.00 price target for the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Adlai Nortye in a report on Tuesday, July 14th. Finally, Wall Street Zen upgraded shares of Adlai Nortye from a “hold” rating to a “buy” rating in a research report on Saturday, August 22nd. Five research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $24.25.

Adlai Nortye Stock Performance

The company has a current ratio of 9.55, a quick ratio of 0.65 and a debt-to-equity ratio of 0.04. The company’s 50-day moving average price is $12.55 and its 200 day moving average price is $11.37.

Insider Activity at Adlai Nortye

In related news, CFO Xiaofeng Ye sold 6,000 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $13.98, for a total transaction of $83,880.00. Following the transaction, the chief financial officer owned 153,424 shares of the company’s stock, valued at approximately $2,144,867.52. This represents a 3.76% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Institutional Investors Weigh In On Adlai Nortye

A number of large investors have recently modified their holdings of the company. Braidwell LP acquired a new stake in shares of Adlai Nortye during the second quarter worth about $9,145,000. Boone Capital Management LLC acquired a new stake in shares of Adlai Nortye in the 2nd quarter valued at about $2,971,000. Affinity Asset Advisors LLC acquired a new position in Adlai Nortye during the first quarter worth approximately $1,140,000. ADAR1 Capital Management LLC purchased a new stake in Adlai Nortye in the first quarter valued at approximately $816,000. Finally, Seven Fleet Capital Management LP acquired a new stake in shares of Adlai Nortye in the second quarter valued at approximately $1,302,000. 35.21% of the stock is owned by hedge funds and other institutional investors.

About Adlai Nortye

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.